439580.KQ BLUEMTEC Co., Ltd.

Healthcare Pharmaceutical Retailers KOSDAQ
1,928 KRW
Close of Oct 31, 2026
1,341 5,480
Market cap
KRW 64.5B
P/E
15.2x
P/B
1.32x
ROE
19.0%
Dividend yield
-
Fundamental score
1.8/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 439580.KQ undervalued?

Graham number
Price1,928
Graham value2,039
Discount5.5%

439580.KQ trades 5.5% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BLUEMTEC Co., Ltd. fundamental analysis

8 of 22 checks passed

ROE 1/2

Moderate return on equity (19.0%), between 10% and 20%.

ROA 1/1

Return on assets (8.2%) is above the industry median (-0.2%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (7.0%) is above the industry median (-33.3%).

Revenue Growth 2/2

Revenue grew 34.1% a year over the past 3 years.

Short-term Liquidity 0/1

Current assets do not cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (1.4%), 40% or less.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 0/1

No interest expense reported.

PE vs Market 0/1

PE (15.2x) is above the market median (11.3x).

PE vs Industry 0/1

PE (15.2x) is above the industry median (11.3x).

PBV 0/1

Price to book (1.3x) is above the industry median (0.8x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 20.1, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

BLUEMTEC Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BLUEMTEC Co., Ltd.

BLUEMTEC Co., Ltd. operates a pharmaceutical distribution platform in South Korea and internationally. It is also involved in the healthcare digital marketing, IT development, fulfilment, pharmaceutical distribution data, and medical staff matching, and logistics businesses. The company was founded in 2015 and is headquartered in Yongin-si, South Korea.

Full company profile